|
Diabetes, Vol 44, Issue 6 658-664, Copyright © 1995 by American Diabetes Association
Interferon expression in the pancreases of patients with type I diabetes
X Huang, J Yuang, A Goddard, A Foulis, RF James, A Lernmark, R Pujol-Borrell, A Rabinovitch, N Somoza and TA Stewart
Department of Endocrine Research, Genetech, Inc., South San Francisco, CA 94080-4990, USA.
We have used a reverse transcriptase-polymerase chain reaction (RT-PCR)
protocol to examine the expression of cytokines in the pancreases and
islets of patients with type I diabetes. We detect a significant increase
in the level of expression of interferon (IFN)-alpha in the pancreases of
the diabetic patients as compared with the control pancreases. In contrast,
IFN-beta was detected at comparable levels in both groups, while IFN-gamma
was detected in three of four control pancreases and one of four pancreases
from the diabetic individuals. The IFN-alpha cDNAs generated by the RT-PCR
were cloned and sequenced to determine which alpha-subtypes were being
expressed. We found that the repertoire of subtypes was quite limited in
any one individual (diabetic or not), although each individual was
different with respect to the pattern of subtypes expressed. We also
examined these pancreases for the expression of tumor necrosis factor
(TNF)-alpha, interleukin (IL)-1 beta, IL-2, IL-4, and IL-6. We found no
detectable expression of TNF-alpha or IL-2 in any pancreases, and the
expression of the other cytokines was variable, with no pattern emerging
from the comparison of the diabetic and nondiabetic individuals. We
conclude that, of the cytokines examined, only IFN-alpha was significantly
increased in the diabetic patients, a result that is consistent with the
possibility that this cytokine is directly involved in the development of
type I diabetes.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Z. Dogusan, M. Garcia, D. Flamez, L. Alexopoulou, M. Goldman, C. Gysemans, C. Mathieu, C. Libert, D. L. Eizirik, and J. Rasschaert
Double-Stranded RNA Induces Pancreatic {beta}-Cell Apoptosis by Activation of the Toll-Like Receptor 3 and Interferon Regulatory Factor 3 Pathways
Diabetes,
May 1, 2008;
57(5):
1236 - 1245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Zanone, E. Favaro, E. Ferioli, G. C. Huang, N. J. Klein, P. C. Perin, M. Peakman, P. G. Conaldi, and G. Camussi
Human pancreatic islet endothelial cells express coxsackievirus and adenovirus receptor and are activated by coxsackie B virus infection
FASEB J,
October 1, 2007;
21(12):
3308 - 3317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T C T M van der Pouw Kraan, C A Wijbrandts, L G M van Baarsen, A E Voskuyl, F Rustenburg, J M Baggen, S M Ibrahim, M Fero, B A C Dijkmans, P P Tak, et al.
Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients
Ann Rheum Dis,
August 1, 2007;
66(8):
1008 - 1014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rasschaert, L. Ladriere, M. Urbain, Z. Dogusan, B. Katabua, S. Sato, S. Akira, C. Gysemans, C. Mathieu, and D. L. Eizirik
Toll-like Receptor 3 and STAT-1 Contribute to Double-stranded RNA+ Interferon-{gamma}-induced Apoptosis in Primary Pancreatic {beta}-Cells
J. Biol. Chem.,
October 7, 2005;
280(40):
33984 - 33991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Devendra, J. Jasinski, E. Melanitou, M. Nakayama, M. Li, B. Hensley, J. Paronen, H. Moriyama, D. Miao, G. S. Eisenbarth, et al.
Interferon-{alpha} as a Mediator of Polyinosinic:Polycytidylic Acid-Induced Type 1 Diabetes
Diabetes,
September 1, 2005;
54(9):
2549 - 2556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. O. Nestle, C. Conrad, A. Tun-Kyi, B. Homey, M. Gombert, O. Boyman, G. Burg, Y.-J. Liu, and M. Gilliet
Plasmacytoid predendritic cells initiate psoriasis through interferon-{alpha} production
J. Exp. Med.,
July 5, 2005;
202(1):
135 - 143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Harii, C. J. Lewis, V. Vasko, K. McCall, U. Benavides-Peralta, X. Sun, M. D. Ringel, M. Saji, C. Giuliani, G. Napolitano, et al.
Thyrocytes Express a Functional Toll-Like Receptor 3: Overexpression Can Be Induced by Viral Infection and Reversed by Phenylmethimazole and Is Associated with Hashimoto's Autoimmune Thyroiditis
Mol. Endocrinol.,
May 1, 2005;
19(5):
1231 - 1250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Alba, M. C. Puertas, J. Carrillo, R. Planas, R. Ampudia, X. Pastor, F. Bosch, R. Pujol-Borrell, J. Verdaguer, and M. Vives-Pi
IFN{beta} Accelerates Autoimmune Type 1 Diabetes in Nonobese Diabetic Mice and Breaks the Tolerance to {beta} Cells in Nondiabetes-Prone Mice
J. Immunol.,
December 1, 2004;
173(11):
6667 - 6675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Maffei, Z. Liu, P. Witkowski, F. Moschella, G. D. Pozzo, E. Liu, K. Herold, R. J. Winchester, M. A. Hardy, and P. E. Harris
Identification of Tissue-Restricted Transcripts in Human Islets
Endocrinology,
October 1, 2004;
145(10):
4513 - 4521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wen, J. Peng, Z. Li, and F. S. Wong
The Effect of Innate Immunity on Autoimmune Diabetes and the Expression of Toll-Like Receptors on Pancreatic Islets
J. Immunol.,
March 1, 2004;
172(5):
3173 - 3180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Padmanabhan
Case Study: Uncontrolled Type 2 Diabetes in a 48-Year-Old Woman on Interferon {beta}-1b Treatment for Multiple Sclerosis
Clin. Diabetes,
January 1, 2004;
22(1):
43 - 45.
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Wang, R. D. Schreiber, and I. L. Campbell
STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-alpha in the central nervous system
PNAS,
December 10, 2002;
99(25):
16209 - 16214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Ronnblom and G. V. Alm
A Pivotal Role for the Natural Interferon {alpha}-producing Cells (Plasmacytoid Dendritic Cells) in the Pathogenesis of Lupus
J. Exp. Med.,
December 17, 2001;
194(12):
F59 - F64.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Chehadeh, J. Kerr-Conte, F. Pattou, G. Alm, J. Lefebvre, P. Wattré, and D. Hober
Persistent Infection of Human Pancreatic Islets by Coxsackievirus B Is Associated with Alpha Interferon Synthesis in beta Cells
J. Virol.,
November 1, 2000;
74(21):
10153 - 10164.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Z. Li, L. Zhao, S. Sandler, and F. A. Karlsson
Expression of Pancreatic Islet MHC Class I, Insulin, and ICA 512 Tyrosine Phosphatase in Low-dose Streptozotocin-induced Diabetes in Mice
J. Histochem. Cytochem.,
June 1, 2000;
48(6):
761 - 768.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Hiromatsu, D. Yang, T. Bednarczuk, I. Miyake, K. Nonaka, and Y. Inoue
Cytokine Profiles in Eye Muscle Tissue and Orbital Fat Tissue from Patients with Thyroid-Associated Ophthalmopathy
J. Clin. Endocrinol. Metab.,
March 1, 2000;
85(3):
1194 - 1199.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. T. Azar, H. Tamim, H. N. Beyhum, M. Z. Habbal, and W. Y. Almawi
Type I (Insulin-Dependent) Diabetes Is a Th1- and Th2-Mediated Autoimmune Disease
Clin. Vaccine Immunol.,
May 1, 1999;
6(3):
306 - 310.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Y. Almawi, H. Tamim, and S. T. Azar
T Helper Type 1 and 2 Cytokines Mediate the Onset and Progression of Type I (Insulin-Dependent) Diabetes
J. Clin. Endocrinol. Metab.,
May 1, 1999;
84(5):
1497 - 1502.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. E. Baldeon, T. Chun, and H. R. Gaskins
Interferon-alpha and interferon-gamma differentially affect pancreatic beta -cell phenotype and function
Am J Physiol Cell Physiol,
July 1, 1998;
275(1):
C25 - C32.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Diabetes Association.
|
|
| |
|